A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
Michal WitkowskiLars WilkinsonNeil WebbAlan WeidsDivina GlahHrvoje VražićPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Novo Nordisk.